Deep Track Capital’s Ocular Therapeutix OCUL Stock Holding History

Deep Track Capital’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$167M	Buy	19,686,282 +11,615,868	+144%	+$111M	2.72%	9
2025 Q4	$98M	Sell	8,070,414 -3,861,723	-32%	-$46.9M	1.75%	17
2025 Q3	$139M	Sell	11,932,137 -2,362,283	-17%	-$28.2M	3.89%	9
2025 Q2	$133M	Hold	14,294,420	–	–	4.25%	8
2025 Q1	$105M	Buy	14,294,420 +1,458,138	+11%	+$11.2M	3.39%	10
2024 Q4	$110M	Buy	12,836,282 +114,822	+0.9%	+$1.12M	4.09%	8
2024 Q3	$111M	Hold	12,721,460	–	–	3.51%	9
2024 Q2	$87M	Hold	12,721,460	–	–	2.6%	14
2024 Q1	$116M	Buy	12,721,460 +3,490,691	+38%	+$24.8M	3.32%	10
2023 Q4	$41.2M	Buy	+9,230,769	New	+$27.3M	1.37%	32

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deep Track Capital's OCUL Position: Q1 2026 in Review

Deep Track Capital increased its Ocular Therapeutix (OCUL) stake by 144% in Q1 2026, buying an estimated $111M and bringing the position to 19,686,282 shares worth $167M. The position accounts for 2.72% of the portfolio, ranked #9.

Deep Track Capital first reported a position in OCUL in Q4 2023 and has held it in 10 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Deep Track Capital held 19,686,282 shares of Ocular Therapeutix worth $167M as of Q1 2026.
Deep Track Capital bought 11,615,868 Ocular Therapeutix shares in Q1 2026, an estimated $111M.
Ocular Therapeutix made up 2.72% of Deep Track Capital's portfolio in Q1 2026, its #9 holding.
Deep Track Capital first reported a position in Ocular Therapeutix in Q4 2023 and has held it in 10 quarters since.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.